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Abstract
Background: To date, conflicting results have been reported about the association between metabolic syndrome
(MetS) and periodonttitis.
Methods: Two hundred and eighty patients with type 2 diabetes were recruited from outpatients visiting diabetes
clinics in Islamic Hospital, Amman-Jordan. The oral hygiene and the periodontal status of all teeth, excluding third
molars, were assessed using the plaque index of Silness and Löe, the gingival index of Löe and Silness, probing
pocket depth (PPD), and clinical attachment level (CAL). Data were analyzed using the general linear model
multivariate procedure with average PPD, average CAL, percent of teeth with CAL ≥3 mm, and percent of teeth
with PPD ≥3 mm as outcome variables and diabetes, MetS and its individual components as predictors.
Results: Overall, 83.2 % of patients with diabetes had MetS. In the multivariate analysis, patients with MetS had a
significantly more severe periodontitis, as measured by average PPD and average CAL (P < 0.005). The extent of
periodontitis, as measured by the percent of teeth with CAL ≥3 mm and the percent of teeth with PPD ≥3 mm,
was also significantly greater among patients with MetS (P < 0.005). As the number of metabolic components
additional to diabetes increased, the odds of having periodontitis increased, and the odds were greatest when all
the components additional to diabetes were present (OR = 10.77, 95 % CI: 2.23 -51.95).
Conclusion: Patients with MetS displayed more severe and extensive periodontitis. Having other MetS components
additional to diabetes increased the odds of having periodontitis.
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Introduction
Metabolic syndrome (MetS) is a complex collection of
components that are thought to arise from a visceral fat-
type obesity involving hypertension and abnormal glucose
and lipid metabolism [1]. The prevalence of MetS in-
creases with age and varies with ethnicity and race [2].
The prevalence of MetS among adults in USA is 22.9 %
[3], which is comparable to its prevalence among Canad-
ian adult population (19.1 %) [4]. Higher MetS prevalence
rates have been observed in the Eastern Mediterranean
countries and Arab populations [5–9]. In Jordan, the
prevalence of MetS among adults was alarmingly high
(36.6 %) [10]. Lower prevalence of MetS has been found
among European adults [11].
Periodontal disease is a group of infectious diseases trig-
gered by periodontopathogens [12]. It is considered the
most common chronic infection worldwide and in the US
[13, 14]. Periodontitis and MetS are multi-factorial dis-
eases sharing a common inflammatory pathway. Many
people with MetS have a low grade systemic inflammation
which is reported by elevated levels of inflammatory medi-
ators such as C-reactive protein (CRP), interleukin-6 (IL-
6), and tumor necrotic factor- α (TNF-α). Moreover,
people who have periodontitis, which is a chronic inflam-
mation, also have elevated levels of inflammatory markers
(CRP, IL-6 and TNF-α) [15, 16]. There is growing evidence
suggesting an association between periodontal disease and
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MetS components since positive correlation between
obesity, hypertension, hyperglycemia and hyperlipidemia
with periodontal disease has been reported [17, 18]. MetS
has been shown to be associated with the prevalence, ex-
tent and severity of periodontal disease [15, 19–21] and a
recent systematic review concluded that subjects affected
by MetS are nearly twice more likely to have periodontitis
than the rest of the population [22]. Furthermore, peri-
odontal disease has effects on the glycemic control [23]
and lipid metabolism [24].
This study is built on the concept that the three dis-
eases (MetS, periodontal disease and diabetes mellitus)
share common pathogenesis. The aim of this study was
to assess the association between MetS and periodontal
disease among patients with type 2 diabetes in Jordan.
Methods
Study population and sampling
The study was approved by the University Ethical Com-
mittee at Jordan University of Science and Technology.
The participants were recruited from outpatients visiting
the diabetes clinics in Islamic Hospital Amman-Jordan,
over a period of six months between June-November
2011. All participants were interviewed and examined
after they signed a written consent form. Patients were
selected using systematic random sampling technique by
choosing every third patient (i.e. patients registered with
numbers such as 3, 6, 9, 12…) attending the clinics.
About half of the interviewed patients met the inclusion
criteria. Patients with a history of a systemic condition
or medication use that might influence the severity of
periodontitis were excluded (i.e. patients with a history
of thyroid diseases, chronic renal problems and connect-
ive tissue diseases). Pregnant women and patients who
were edentulous and those who had undergone peri-
odontal treatment within the preceding 6 months were
also excluded.
The power of this study to detect the association be-
tween MetS and periodontal disease given our sample
size was calculated. To detect a minimal odds ratio of 3
at alpha level of 5 % in a sample that included 233 pa-
tients with MetS and assuming that 14 % of patients
without MetS had periodontal disease, the power was
calculated as 99 %. The power calculations were per-
formed using Sample size online calculator (http://sampsize.
sourceforge.net/iface/s3.html).
Data collection
Data were collected by a questionnaire answered by
patients through personal interview and clinical ex-
amination. The questionnaire included questions about
socio-demographic variables, medical history, smoking
history, previous dental history, oral hygiene practice and
clinical findings associated with periodontal examination.
Participants were assured of the confidentiality of all ob-
tained information and that collected data will only be
used for scientific purposes.
Diabetes mellitus
Only patients with type 2 diabetes were included in this
study. Patients were diagnosed with diabetes mellitus if they
had fasting plasma glucose (FPG) ≥ 100 mg/dl or if they
were taking medications for type 2 diabetes mellitus. Con-
trol of diabetes mellitus was investigated through glycated
hemoglobin test (HbA1c). The FPG and HbA1c values
were taken from recent tests included in patients’ files.
Hypertension
Hypertension was defined as systolic blood pressure ≥
130 mmHg or diastolic blood pressure ≥ 85 mmHg, or
under treatment of previously diagnosed hypertension as
reported in patients’ medical records. Blood pressure was
measured by a qualified nurse using a mercury sphygmo-
manometer on the same day of periodontal examination.
Hyperlipidemia
The diagnosis of hyperlipidemia was made by an endo-
crinologist based on the measurements of triglycerides
(TG) and high density lipoproteins (HDL): TG ≥ 150 mg/
dl and/or (HDL cholesterol level < 40 mg/dl in males and
< 50 mg/dl in females), or if the patient was currently on
specific treatment for lipid abnormalities.
Obesity
The participants were diagnosed as obese by measuring
the waist circumference (WC), using a circumference
measuring tape. The readings were rounded to the near-
est centimeter. The diagnosis was made if the waist cir-
cumference was ≥ 94 cm for men and ≥ 80 cm for
women. The weight was measured using a mechanical
flat scale to the nearest kilogram, and height was mea-
sured to the nearest centimeter using a measuring rod.
All these measurement were taken at the same day of
examination, with the participants wearing light clothing
and no shoes.
MetS definition
MetS was defined according to the International Diabetes
Federation (IDF) definition [25]. According to the IDF def-
inition, a person was defined as having MeS if he or she
had central obesity (defined as waist circumference ≥94 cm
for men and ≥80 cm for women, with ethnicity specific
values for other groups) plus any two of the following four
factors: 1) Raised TG level: ≥150 mg/dL (1.7 mmol/L), or
specific treatment for this lipid abnormality, 2) Reduced
HDL cholesterol: <40 mg/dL (1.03 mmol/L) in males and
<50 mg/dL (1.29 mmol/L) in females, or specific treatment
for this lipid abnormality, 3) Raised blood pressure: systolic
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BP ≥130 or diastolic BP ≥85 mm Hg, or treatment of pre-
viously diagnosed hypertension, 4) Raised fasting plasma
glucose (FPG) ≥100 mg/dL (5.6 mmol/L), or previously di-
agnosed type 2 diabetes.
Periodontal clinical examination
The oral hygiene and the periodontal status of all teeth,
excluding third molars, were assessed using, plaque
index (PI) of Silness & Löe (1964) [26], probing pocket
depth (PPD), and clinical attachment loss (CAL). Sterile
dental mirrors and explorers were used to assess plaque
accumulation and gingival status. Hu-Friedy periodontal
probes with Williams’s markings (Diatech, Switzerland)
were used to measure PPD and CAL. All teeth (exclud-
ing third molars), and six surfaces of each studied tooth
(mesio-facial, mid-facial, disto-facial, mesio-lingual, mid-
lingual, and disto-lingual) were assessed and scored for
PI, GI, PPD and CAL. Plaque index was scored as fol-
lows: 0 = no plaque/debris 1 = A film of plaque adhering
to the free gingival margin and adjacent area of the
tooth. 2 =Moderate accumulation of soft deposit s
within the gingival pocket, or the tooth and gingival
margin which can be seen with the naked eye. 3 = Abun-
dance of soft matter within the gingival pocket and/or
on the tooth and gingival margin. The highest score of
each reading was taken into consideration. Data were re-
corded on periodontal examination form.
Disease extent was defined by the percentage of deep
pockets. The mean of the deepest reading for PPD and
CAL was calculated within each mouth by dividing the
value of deepest pockets on the total number of deep
pockets. Periodontitis was defined as presence of four or
more teeth with highest reading of PPD ≥ 3 mm and
CAL ≥ 3 mm [27].
Reliability of questionnaire and periodontal examination
Clinical examinations were performed by one skilled
examiner (RA). Before the beginning of the study, the
measurement reliability was determined on the basis of
examinations performed on 10 patients with severe peri-
odontitis. Of the replications, 98 % were within 1 mm
for PDs, and 97 % were within 1 mm for CALs.
Data management and analysis
The Statistical Package for Social Sciences software
(SPSS Inc., version 15, Chicago, IL, USA) was used for
data processing and data analysis. Characteristics of sub-
jects’ variables were described using frequency distribution
for categorical variables and mean and standard deviation
for continuous variables. The Chi2 test was used to assess
the association between categorical variables.
The multivariate analysis of the association between dif-
ferent disease status and periodontal parameters (average
PPD, average CAL) and percentage of teeth with (PPD
≥3 mm, PPD ≥4 mm, PPD ≥5 mm, PPD ≥6 mm, CAL
≥3 mm, CAL ≥4 mm, CAL ≥5 mm and CAL ≥6 mm) was
conducted using the General Linear Model procedure.
Multivariate binary logistic regression was conducted to
determine the association between each disease group
(i.e. group of patients with MetS and group of patients
with diabetes) and the prevalence of periodontal disease
after adjusting for important variables. All variables that
were significantly associated with periodontal disease
constituted the best regression model. The association
between obesity, hypertension, and hyperlipidemia, with
diabetes and periodontal disease was tested, in separate
models, for each disease group after adding that indica-
tor to the best model. The association between diabetes,
the increasing number of MetS components and peri-
odontal disease was tested too. The statistical signifi-
cance of the two-way interactions between independent
variables was assessed with the use of forward stepwise
regression.
The two-way interaction terms, one at a time, were
added in the model containing all the main effects and
were assessed for their significance using the likelihood
ratio test. Crude odds ratios (ORs) and their 95 % confi-
dence interval (CI) were calculated. A p-value of <0.05
was considered statistically significant.
Results
This study included a total of 280 patients with type 2 dia-
betes mellitus. Overall, 83.2 % of patients with diabetes
had MetS. The patients aged between 21 and 80 years
with a mean (±SD) age of 53.8 (±9.6) years. Socio-
demographic, dental, anthropometric, clinical, and rele-
vant characteristics of the participants are shown in
Tables 1 and 2. About half (50.7 %) of patients were males
and 49.3 % were females. About one third of patients
(32 %) had university level education. Almost 30 % of pa-
tients reported brushing their teeth twice daily. Nearly half
(51.8 %) of patients had duration of diabetes of ≤ 5 years,
28 % were taking insulin therapy, and 93.2 % were on oral
hypoglycemic medications. Only 21.8 % of patients were
well controlled (HbA1c ≤6.5 %). The majority (87.5 %)
of the participants were obese, 87.1 % had elevated
blood pressure, 65 % had increased triglycerides level
(≥150 mg/dl), and 46.1 % had low HDL level.
Table 3 illustrates the extent and severity of periodon-
tal disease according to MetS after adjusting for average
PI, age, family income, residency area, smoking, teeth
brushing and number of missing teeth. Patients with
MetS had a significantly higher mean PPD (P < 0.005)
and CAL (P = 0.001). The extent of periodontal disease
was also significantly higher in patients with MetS as
measured by average percent of teeth with the deepest
CAL ≥3 mm (P < 0.005), CAL ≥4 mm (P < 0.005), and
CAL ≥5 mm (P < 0.005).
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Table 4 demonstrates the extent and severity of peri-
odontal disease according to the number of metabolic
abnormalities in the multivariate analysis. As the num-
ber of metabolic abnormalities in addition to diabetes in-
creased; the severity of periodontal disease, as measured
by average PPD and average CAL, significantly increased.
The increasing number of components of MetS was sig-
nificantly associated with higher extent of periodontal
disease as measured by the average percent of teeth with
CAL ≥3 mm, ≥4 mm, ≥5 mm, and ≥6 mm.
The prevalence of periodontal disease according to
MetS and its components is shown in Table 5. The preva-
lence of periodontal disease was higher among those who
had MetS compared to those who did not have MetS
(44.6 % vs. 14.9 %). The prevalence of periodontal disease
in patients with diabetes was significantly increased as the
number of metabolic components increased (P < 0.005).
Diabetes mellitus was associated with significantly higher
prevalence of periodontal disease when accompanied with
Table 1 Socio-demographic, dental and relevant characteristics
of 280 patients with type 2 diabetes
Variable n (%)
Gender:
Male 142 (50.7)
Female 138 (49.3)
Age (years):
≤45 56 (20.0)
46–55 107 (38.2)
>55 117 (41.8)
Family income (JD):
≤500 JD 168 (60)
>500 112 (40)
Education:
Elementary 107 (38.2)
Secondary 86 (30.7)
University 87 (31.1)
Residency area:
Urban 271 (96.8)
Rural 9 (3.2)
Smoking:
Non-smoker 185 (66.1)
X-smoker 34 (12.1)
Smoker 61 (21.8)
Teeth brushing:
Infrequent 87 (31.1)
Once/day 109 (38.9)
Twice/day 84 (30.0)
Having fixed prosthesis 186 (66.4)
Number of missing teeth:
0 53 (18.7)
1–7 120 (43.0)
8–18 107 (40.3)
Periodontitis 111 (39.6)
Table 2 Anthropometric, clinical and relevant characteristics of
280 patients with type 2 diabetes
Variables n (%)
Diabetes duration (years):
≤5 145 (51.8)
>5 135 (48.2)
HbA1c (%):
≤6.5 61 (21.8)
>6.5 219 (78.2)
Diabetes treatment:
On insulin 78 (27.9)
On oral hypoglycemic drugs 261 (93.2)
Increased Waist circumference 245 (87.5)
Elevated blood pressure 244 (87.1)
Increased triglycerides level 182 (65)
Low HDL 129 (46.1)
Metabolic syndrome (MetS) 233 (83.2)
Table 3 Extent and severity of periodontal disease according to
metabolic syndrome (MetS) among 280 patients with type 2
diabetes
Variable Metabolic syndrome P-value*
No (n = 47) Yes (n = 233)
Mean (SD) Mean (SD)
Average Probing Pocket
Depth (PPD)
1.29 (0.32) 1.77 (0.42) <0.005
Average Clinical Attachment
Level (CAL)
1.52 (1.34) 2.86 (1.59) 0.001
Average percent of teeth
with deepest:
PPD≥ 3 1.00 (2.83) 11.08 (21.89) 0.038
PPD≥ 4 0.33 (1.36) 7.03 (20.77) 0.159
PPD≥ 5 0.0 (0.0) 5.24 (20.43) 0.297
PPD≥ 6 0.0 (0.0) 4.40 (20.30) 0.392
Average percent of teeth
with deepest:
CAL≥ 3 13.25 (23.24) 54.54 (28.13) <0.005
CAL≥ 4 10.44 (17.79) 40.13 (30.05) <0.005
CAL≥ 5 3.02 (6.93) 24.03 (24.75) <0.005
CAL≥ 6 1.89 (5.09) 14.99 (22.76) 0.160
*Adjusted for average PI, age, family income, residency area, smoking, teeth
brushing, and number of missing teeth
Alhabashneh et al. Journal of Diabetes & Metabolic Disorders  (2015) 14:67 Page 4 of 7
increased waist circumference (P = 0.011), increased tri-
glycerides (P = 0.005), and decreased HDL (P = 0.001), but
not when accompanied with hypertension (P = 0.119).
Model I in Table 6 shows that patients with MetS were
almost 3 times (OR = 3.28, 95 % CI: 1.3-8.3) more likely
to have periodontal disease compared to patients with-
out MetS. In model II, patients with diabetes were about
6 times (OR = 5.73, 95 % CI: 1.15-28.59) more likely to
have periodontal disease if they had two more compo-
nents of MetS compared to those who had one add-
itional component only. Patients who had all the other
components of metabolic syndrome had much higher
odds of having periodontal disease (OR = 10.77, 95 % CI:
2.23-51.95) compared to those who had one additional
component only. In model III, of the individual compo-
nents of MetS, only HDL level was significantly associ-
ated with increased odds of having periodontal disease
(OR = 1.99, 95 % CI: 1.15-3.46).
Discussion
This study showed a positive association between peri-
odontitis and MetS. Periodontitis was more common
and severe in diabetic patients with MetS in Jordan com-
pared to patients with no MetS. As the number of meta-
bolic components additional to diabetes increased the
severity and extent of periodontal disease increased.
Our study is the first in the Middle East that explores
the association between MetS and periodontal disease
among patients with diabetes. Other studies compared
periodontal disease between patients with MetS and pa-
tients without MetS only without investigating the effect
of individual components of MetS.
Table 4 Extent and severity of periodontal disease according to the number of metabolic syndrome (MetS) components among
280 patients with type 2 diabetes
The number of MetS components additional to diabetes mellitus
One component
n = 31
Mean (SD)
Two components
n = 52
Mean (SD)
Three components
n = 115
Mean (SD)
Four components
n = 82
Mean (SD)
P-value*
Average Pocket Probing Depth (PPD) 1.25 (0.33) 1.71 (0.33) 1.7 (0.43) 1.85 (0.46) <0.005
Average Clinical Attachment Level (CAL) 1.11 (1.22) 2.33 (1.3) 2.85 (1.6) 3.1 (1.65) <0.005
Average percent of teeth with deepest:
PPD≥ 3 0.91 (2.61) 6.58 (10.67) 10.40 (23.01) 12.95 (23.64) 0.459
PPD≥ 4 0.38 (1.53) 1.82 (5.17) 7.21 (22.43) 8.76 (22.36) 0.345
PPD≥ 5 0.0 (0.0) 0.74 (18.77) 6.03 (22.31) 5.98 (21.77) 0.437
PPD≥ 6 0.0 (0.0) 0.07 (0.5) 5.32 (22.32) 5.00 (21.66) 0.433
Average percent of teeth with deepest:
CAL≥ 3 9.82 (15.73) 39.54 (28.22) 52.94 (29.46) 59.5 (28.45) <0.005
CAL≥ 4 6.95 (13.07) 27.27 (27.04) 39.01 (28.72) 45.34 (32.2) <0.005
CAL≥ 5 2.77 (7.54) 16.32 (20.83) 21.66 (24.11) 28.22 (26.23) 0.005
CAL≥ 6 1.04 (3.34) 6.99 (9.93) 13.08 (20.61) 20.48 (27.99) 0.004
*Adjusted for average PI, age, family income, residency area, smoking, teeth brushing, and number of missing teeth
Table 5 Prevalence of periodontal disease among 280 patients
with diabetes mellitus according to metabolic syndrome (MetS)
and its components
Periodontitis p-value
Non (%) Yesn (%)
Metabolic syndrome (MetS) <0.005
No 40 (85.1) 7 (14.9)
Yes 129 (55.4) 104 (44.6)
Number of metabolic
components additional to
diabetes mellitus
1 component 29 (93.5) 2 (6.5) <0.005
2 components 32 (61.5) 20 (38.5) <0.005
3 components 72 (62.6) 43 (37.4) <0.005
4 components 36 (43.9) 46 (56.1) <0.005
Waist circumference 0.011
Normal 28 (80) 7 (20)
Increased 141 (57.6) 104 (42.4)
Blood pressure 0.119
Normal 26 (72.2) 10 (27.8)
Elevated blood pressure 143 (58.6) 101 (41.4)
Triglycerides 0.005
Normal 70 (71.4) 28 (28.6)
Increased 99 (54.4) 83 (45.6)
HDL 0.001
Normal 105 (69.5) 46 (30.5)
Low 64 (49.6) 65 (50.4)
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The findings of this study are consistent with the study
conducted by Khader et al. (2008) [19] in Jordan and are in
support of other studies‘ findings [20, 21]. Shimazaki et al.
(2007) [28] reported that MetS is associated with increased
risk of periodontal disease among Japanese women. On the
other hand, Morita et al. (2010) [16] concluded that pres-
ence of periodontal pockets was associated with a positive
conversion of MetS components, suggesting that prevent-
ing periodontal disease may prevent MetS. These studies
may propose a two way relationship. However, longitudinal
and interventional studies should be performed to investi-
gate such a relationship.
In this study when each component additional to dia-
betes was analyzed separately, increased waist circumfer-
ence (WC) and low HDL level were associated with
significantly higher extent and severity of periodontal
disease. Increased triglycerides (TG) level was associated
with significant increase in the extent but not severity of
periodontal disease, while hypertension was not signifi-
cantly associated with either extent or severity of peri-
odontal disease. This was comparable with the results
reported by Shimazaki et al. (2007) [28], as increased
WC, low HDL and fasting blood sugar had significant
relationships with periodontal disease.
In contrast, Kushiyama et al. (2009) [20] reported that
of the five MetS components, only high blood pressure
and low HDL were each significantly associated with
deep probing depths.
When the extent and severity of periodontal disease
were analyzed according to the number of MetS compo-
nents in multivariate analysis, the number of compo-
nents additional to diabetes increased was associated
with increased extent and severity of periodontal disease.
This finding was consistent with results of other studies
[15, 19, 20, 28]. It is important to mention that these
studies were designed to compare periodontal disease
between patients with MetS and patients without MetS,
but not in patients who had diabetes and MetS. In this
study, the effect of diabetes on periodontal disease was
the principal factor to which the effect of other compo-
nents was added, while the other studies did not take
into consideration the well established relationship be-
tween diabetes and periodontal disease.
In our study, obesity was significantly associated with
higher extent and severity of periodontal disease. This find-
ing was consistent with the findings of another study in
Jordan by Khader et al. (2009) [29]. Low HDL level was
strongly associated with increased extent and severity of
periodontal disease, while elevated TG levels were associ-
ated with significant increase in average CAL (severity) and
percent of teeth with deepest CAL ≥ 3, ≥ 4 mm (extent).
These findings are in agreement with the study conducted
by Fentoğlu et al. (2009) [30]. However, Saxlin et al. (2008)
[31] found no association between level of serum lipids and
periodontal disease in normal-weight subjects, while obese
subjects with high TG levels, and/or low HDL levels could
be at high risk of periodontal disease.
Diabetic patients who had MetS had significantly higher
prevalence of periodontal disease than those without
MetS. This finding confirmed the results of Li et al. (2009)
[15] and Kushiyama et al. (2009) [20]. In this study the
prevalence of periodontitis in patients with diabetes was
significantly increased as the number of MetS com-
ponents increased. This was similar to other studies;
Kushyiama et al. (2009) [20] concluded that subjects with
three, four or five components of MetS exhibited a signifi-
cantly higher prevalence of periodontal disease and Li
et al. (2009) [15] found that prevalence of periodontal
disease was less in subjects bearing fewer than two of
metabolic components. Also, Hasegawa et al. (2004) [32]
Table 6 Multivariate analysis of association between metabolic
syndrome (MetS) and its components with periodontal disease
in separate models among 280 patients with diabetes mellitus
Odds ratio
(95 % confidence
interval) of having
periodontitis
p-value*
Model I
Metabolic syndrome (MetS)
No 1
Yes 3.28 (1.30, 8.30) 0.012
Model II: Number of MetS
additional to diabetes
1 component 1
2 components 5.73 (1.15, 28.59) 0.03
3 components 4.82 (1.03, 22.65) 0.046
4 components 10.77 (2.23, 51.95) 0.003
Model III: Individual components
of MetS
Waist circumference
Normal 1
Increased 1.74 (0.63, 4.79) 0.286
Blood pressure
Normal 1
Elevated 1.12 (0.43, 2.90) 0.812
Triglycerides
Normal 1
Increased 1.41 (0.77, 2.60) 0.268
HDL
Normal 1
Low 1.99 (1.15, 3.46) 0.004
*In the three models, the associations between periodontal disease and
metabolic syndrome, individual components, and their combinations were
adjusted for average PI, age, family income, residency area, smoking, teeth
brushing, and number of missing teeth
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observed that Japanese urban women who had three or
more components had a higher prevalence of periodontal
disease than those who had less than two components.
In this study only low HDL level was significantly asso-
ciated with increased odds of having periodontal disease
in the multivariate analysis. Alike, Shimazaki et al. (2007)
[28] reported that of the five components of MetS, low
HDL level had the highest odds ratio and was statistically
significant for a greater PPD and CAL. Similarly, Nibali
et al. (2007) [33] reported that periodontitis exhibited a
significant association with low HDL, high LDL, and ele-
vated fasting blood sugar.
In conclusion, patients with MetS displayed more severe
and extensive periodontitis. Having other MetS compo-
nents additional to diabetes increased the odds of having
periodontitis. Given the study design we used, our findings
reflect the cumulative and additive effects of metabolic ab-
normalities on the risk of periodontal disease. Longitu-
dinal and interventional studies are needed to confirm the
study findings.
Competing interests
The authors declare that they have no competing interests.
Authors’ contributions
RA main researcher, supervise data collection, and dental examination
writing manuscript. YK data analyses, editted the manuscript. ZH data
collection, examination, thesis writing. FA writing results, manuscript editting.
All authors read and approved the final manuscript.
Source of funding statement
This study was partially supported by the University of Science and
Technology Research Fund.
Received: 28 January 2015 Accepted: 15 July 2015
References
1. Eckel RH, Grundy SM, Zimmet PZ. The metabolic syndrome. Lancet.
2005;365(9468):1415–28.
2. Onat A. Metabolic syndrome: nature, therapeutic solutions and options.
Expert Opin Pharmacother. 2011;12(12):1887–900.
3. Beltrán Sánchez H, Harhay MO, Harhay MM, McElligott S. Prevalence and
trends of metabolic syndrome in the adult U.S. population, 1999–2010.
J Am Coll Cardiol. 2013;62(8):697–703.
4. Riediger ND, Clara I. Prevalence of metabolic syndrome in the Canadian
adult population. CMAJ. 2011;183(15):E1127–34.
5. Abdul-Rahim HF, Husseini A, Bjertness E, Giacaman R, Gordon NH, Jervell J.
The metabolic syndrome in the West Bank population: An urban–rural
comparison. Diabetes Care. 2001;24(2):275–9.
6. Al-Lawati JA, Mohammed AJ, Al-Hinai HQ, Jousilahti P. Prevalence of the
metabolic syndrome among Omani adults. Diabetes Care. 2003;26(6):1781–5.
7. Jaber LA, Brown MB, Hammad A, Zhu Q, Herman WH. The prevalence of
the metabolic syndrome among Arab Americans. Diabetes Care.
2004;27(1):234–8.
8. Onat A Ceyhan K, Basar Ö, Erer B, Toprak S, Sansoy V. Metabolic syndrome:
major impact on coronary risk in a population with low cholesterol levels – a
prospective and cross-sectional evaluation. Atherosclerosis. 2002;165:285–9.
9. Zabetian A, Hadaegh F, Azizi F. Prevalence of metabolic syndrome in Iranian
adult population, concordance between the IDF with the ATPIII and the
WHO definitions. Diabetes Res Clin Pract. 2007;77:251–7.
10. Khader Y, Bateiha A, El-Khateeb M, Al-Shaikh A, Ajlouni K. High prevalence
of the metabolic syndrome among Northern Jordanians. J Diabetes
Complicat. 2007;21(4):214–9.
11. Hu G, Qiao Q, Tuomilehto J, Balkau B, Borch-Johnsen K, Pyorala K, et al.
Prevalence of the metabolic syndrome and its relation to all-cause and
cardiovascular mortality in nondiabetic European men and women. Arch
Intern Med. 2004;164:1066–76.
12. Page RC, Kornman KS. The pathogenesis of human periodontitis.
Periodontol. 2000;14:9–11.
13. Loesche WJ, Grossman NS. Periodontal disease as a specific, albeit chronic,
infection: diagnosis and treatment. Clin Microbial Rev. 2001;14(4):727–52.
14. Eke PI, Dye BA, Wei L, Thornton-Evans GO. Prevalence of periodontitis in
adults in the United States: 2009 and 2010. Dent Res J. 2012;91(10):914–20.
15. Li P, He L, Sha Y, Luan Q. Relationship of metabolic syndrome to chronic
periodontitis. J Periodontol. 2009;80(4):541–9.
16. Morita T, Yamazaki Y, Mita A, Takada K, Seto M, Nishinoue N, et al. A cohort
study on the association between periodontal disease and the
development of metabolic syndrome. J Periodontol. 2010;81(4):512–9.
17. Abreu LMG, Lopes FF, Pereira AFV, Pereira ALA, Alves CMC. The interface
between metabolic syndrome and periodontal disease. RSBO.
2012;9(4):434–41.
18. Gurav AN. The association of periodontitis and metabolic syndrome. Dent
Res J (Isfahan). 2014;11(1):1–10.
19. Khader Y, Khassawneh B, Obeidat B, Hammad M, El-Salem K, Bawadi H, et al.
Periodontal status of patients with metabolic syndrome compared to those
without metabolic syndrome. J Periodontol. 2008;79(11):2048–53.
20. Kushiyama M, Shimazaki Y, Yamashita Y. Relationship between metabolic
syndrome and periodontal disease in Japanese adults. J Periodontol.
2009;80(10):1610–5.
21. Benquiqui C, Bongrad V, Ruidavets JB, Chamontin B, Sixous M, F Errieres J,
et al. Metabolic syndrome, insulin resistance, and periodontitis: a cross-
sectional study in a middle-aged French population. J Clin Periodontol.
2010;37(7):601–8.
22. Nibali L, Tatarakis N, Needleman I, Tu YK, D‘Aiuto F, Rizzo M, et al.
Association between metabolic syndrome and periodontitis: a systematic
review and meta-analysis. J Clin Endocrinol Metab. 2013;98(3):913–20.
23. Janket SJ, Wightman A, Baird AE, Van Dyke TE, Jones JA. Does periodontal
treatment improve glycemic control in diabetic patients? A meta-analysis of
intervention studies. JDent Res. 2005;84(12):1154–9.
24. Iacopino AM, Cutler CW. Path physiological relationships between
periodontitis and systemic disease: recent concepts involving serum lipids.
J Periodontol. 2000;71(8):1375–84.
25. Alberti KG, Zimmet P, Shaw J. IDF Epidemiology task force consensus group.
The metabolic syndrome–a new worldwide definition. Lancet.
2005;366:1059–62.
26. Silness J, Loe H. Periodontal disease in pregnancy II. Correlation between
oral hygiene and periodontal condition. Acta Odontol Scand. 1964;22:121–35.
27. Brown LJ, Brunelle JA, Kingman A. Periodontal status in the United States,
1988–1991: Prevalence, extent, and demographic variation. J Dent Res.
1996;75:672–83.
28. Shimazaki Y, Saito T, Yonemoto K, Kiyohara Y, Iida M, Yamashita Y.
Relationship of metabolic syndrome to periodontal disease in Japanese
women: the Hisayama Study. J Dent Res. 2007;86(3):271–5.
29. Khader YS, Bawadi HA, Haroun TF, Alomari M, Tayyem RF. The Association
between periodontal disease and obesity among adults in Jordan. J Clin
Periodontol. 2009;36(1):18–24.
30. Fentoğlu O, Oz G, Taşdelen P, Uskun E, Aykaç Y, Bozkurt FY. Periodontal
status in subjects with hyperlipidemia. J Periodontol. 2009;80(2):267–73.
31. Saxlin T, Suominen-Taipale L, Kattainen A, Marniemi J, Knuuttila M, Ylostalo
P. Association between serum lipid levels and periodontal infection. J Clin
Periodonto. 2008;35(12):1040–7.
32. Hasegawa T, Watase H. Multiple risk factors of periodontal disease: A study
of 9260 Japanese nonsmokers. Geriatr Gerontol Int. 2004;4(1):37–43.
33. Nibali L, D’Aiuto F, Griffiths G, Patel K, Suvan J, Tonetti MS. Severe
periodontitis is associated with systemic inflammation and a dysmetabolic
status: a case–control study. J Clin Periodontol. 2007;34(11):931–7.
Alhabashneh et al. Journal of Diabetes & Metabolic Disorders  (2015) 14:67 Page 7 of 7
